First AI-Designed Protein Enters Human Trials
A cancer-targeting protein designed entirely by AI has cleared safety hurdles and is now being tested in patients—a milestone for computational biology.
Clinical Trials - Latest News & Analysis
In-depth coverage, analysis, and updates on Clinical Trials in AI and tech. 2 articles on AI Pulse.
AI-Designed Cancer Drug Shows 78% Tumor Reduction in Phase 2 Trials
The molecule was designed entirely by AI in 18 months instead of the typical 5 years. Phase 3 trials begin next month.